Hydration Pharmaceuticals Company Ltd has released a press release.
FY24 Appendix 4E
Filed with ASX ·
On 6ix: 6ix.com/news/fy24-appendix-4e-19
6ix hasn’t read this filing yet.
Hydration Pharmaceuticals Company Limited on 6ix
Story so far
Earlier from Hydration Pharmaceuticals
- Q4 FY24 Quarterly Activities Report (App 4C)
- US Operations Update
- Q3 FY24 Quarterly Activities Report (App 4C)
- Completion of divesture of non-US assets
- Divesture of Hydralyte's non-US assets
Later from Hydration Pharmaceuticals
- Strategic Placement and Rights Issue to Raise up to $1.25m
- Amended Rights Issue Timetable
- Entitlement Offer Booklet
- Q1 CY25 Sales Update
- Q1 FY25 Quarterly Activities Report (App 4C)
Follow Hydration Pharmaceuticals into a list and get an email when it puts out news.
Follow Hydration Pharmaceuticals